Santhera Pharmaceuticals Holding AG (XSWX:SANN) FCF Yield % : 40.61 (As of Dec. 12, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Santhera Pharmaceuticals Holding AG's Trailing 12-Month Free Cash Flow is CHF47.3 Mil, and Market Cap is CHF119.7 Mil. Therefore, Santhera Pharmaceuticals Holding AG's FCF Yield % for today is 40.61%.

The historical rank and industry rank for Santhera Pharmaceuticals Holding AG's FCF Yield % or its related term are showing as below:

XSWX:SANN' s FCF Yield % Range Over the Past 10 Years
Min: -255 Med: -16.66 Max: 48.57
Current: 40.61

During the past 13 years, the highest FCF Yield % of Santhera Pharmaceuticals Holding AG was 48.57%. The lowest was -255.00%. And the median was -16.66%.

XSWX:SANN's FCF Yield % is ranked better than
99.6% of 1507 companies
in the Biotechnology industry
Industry Median: -12.65 vs XSWX:SANN: 40.61

Santhera Pharmaceuticals Holding AG's FCF Margin % for the quarter that ended in Jun. 2024 was -108.79%.

Santhera Pharmaceuticals Holding AG FCF Yield % Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG FCF Yield % Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

1.87

-85.78

-56.67

-37.18

21.20

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Yield %	Get a 7-Day Free Trial															-49.65	-39.35	-40.49	112.84	-31.58

Competitive Comparison of Santhera Pharmaceuticals Holding AG's FCF Yield %

For the Biotechnology subindustry, Santhera Pharmaceuticals Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Santhera Pharmaceuticals Holding AG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Santhera Pharmaceuticals Holding AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Santhera Pharmaceuticals Holding AG's FCF Yield % falls into.

Santhera Pharmaceuticals Holding AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Santhera Pharmaceuticals Holding AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	23.528	/	111.002112
	=	21.20%

Santhera Pharmaceuticals Holding AG's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-15.355	*	2	/	97.240296
	=	-31.58%

Santhera Pharmaceuticals Holding AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Santhera Pharmaceuticals Holding AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Santhera Pharmaceuticals Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

SANNz:UK 0QN1:UK

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives the majority of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG Headlines

No Headlines